Magnetic resonance imaging for brain stereotactic radiotherapy : A review of requirements and pitfalls.

Magnetresonanztomographie für die stereotaktische Strahlentherapie des Gehirns : Anforderungen und Fehlerquellen – eine Übersicht.

Journal

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
ISSN: 1439-099X
Titre abrégé: Strahlenther Onkol
Pays: Germany
ID NLM: 8603469

Informations de publication

Date de publication:
May 2020
Historique:
received: 20 01 2020
accepted: 03 03 2020
pubmed: 25 3 2020
medline: 25 9 2020
entrez: 25 3 2020
Statut: ppublish

Résumé

Due to its superior soft tissue contrast, magnetic resonance imaging (MRI) is essential for many radiotherapy treatment indications. This is especially true for treatment planning in intracranial tumors, where MRI has a long-standing history for target delineation in clinical practice. Despite its routine use, care has to be taken when selecting and acquiring MRI studies for the purpose of radiotherapy treatment planning. Requirements on MRI are particularly demanding for intracranial stereotactic radiotherapy, where accurate imaging has a critical role in treatment success. However, MR images acquired for routine radiological assessment are frequently unsuitable for high-precision stereotactic radiotherapy as the requirements for imaging are significantly different for radiotherapy planning and diagnostic radiology. To assure that optimal imaging is used for treatment planning, the radiation oncologist needs proper knowledge of the most important requirements concerning the use of MRI in brain stereotactic radiotherapy. In the present review, we summarize and discuss the most relevant issues when using MR images for target volume delineation in intracranial stereotactic radiotherapy.

Identifiants

pubmed: 32206842
doi: 10.1007/s00066-020-01604-0
pii: 10.1007/s00066-020-01604-0
pmc: PMC7182639
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

444-456

Références

Semin Radiat Oncol. 2014 Jul;24(3):160-8
pubmed: 24931086
Neurosurgery. 1994 Oct;35(4):696-703; discussion 703-4
pubmed: 7808613
AJNR Am J Neuroradiol. 1994 Jan;15(1):37-44
pubmed: 8141064
Technol Cancer Res Treat. 2017 Dec;16(6):1120-1129
pubmed: 29332453
Phys Med Biol. 2010 Nov 21;55(22):6601-15
pubmed: 20962365
Stereotact Funct Neurosurg. 2015;93(6):380-6
pubmed: 26671683
Strahlenther Onkol. 2020 May;196(5):417-420
pubmed: 32211940
Neurosurgery. 2013 May;72(5):691-701
pubmed: 23381488
Front Oncol. 2019 Jul 17;9:647
pubmed: 31380283
Int J Radiat Oncol Biol Phys. 2014 Dec 1;90(5):1234-41
pubmed: 25442348
Radiother Oncol. 1997 Jan;42(1):1-15
pubmed: 9132820
J Neurosurg. 2016 Feb;124(2):489-95
pubmed: 26361281
Magn Reson Imaging. 2004 May;22(4):529-42
pubmed: 15120173
Phys Med Biol. 2013 Feb 7;58(3):465-77
pubmed: 23302471
Strahlenther Onkol. 2019 Aug;195(8):734-744
pubmed: 31123785
Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):291-8
pubmed: 10802351
Neuro Oncol. 2015 Sep;17(9):1188-98
pubmed: 26250565
Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):126-32
pubmed: 26279030
IEEE Trans Med Imaging. 1992;11(3):319-29
pubmed: 18222873
Neuroimage. 2006 Apr 1;30(2):436-43
pubmed: 16300968
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):727-733
pubmed: 29953911
Neurosurgery. 1992 Mar;30(3):402-6; discussion 406-7
pubmed: 1620305
Magn Reson Med Sci. 2008;7(1):13-21
pubmed: 18460844
J Neurosurg. 2006 Jan;104(1):157-62
pubmed: 16509161
Phys Med Biol. 2005 Apr 7;50(7):1343-61
pubmed: 15798328
Med Phys. 2007 Feb;34(2):388-99
pubmed: 17388155
Radiother Oncol. 2019 Jul;136:56-63
pubmed: 31015130
Radiother Oncol. 1992 Feb;23(2):127-30
pubmed: 1546188
Magn Reson Med. 1995 Jul;34(1):65-73
pubmed: 7674900
Magn Reson Med. 1990 Jul;15(1):152-7
pubmed: 2374495
J Appl Clin Med Phys. 2004 Summer;5(3):66-79
pubmed: 15753941
Med Phys. 2012 Dec;39(12):7185-93
pubmed: 23231269
Neurosurgery. 1999 Nov;45(5):1156-61; discussion 1161-3
pubmed: 10549932
Strahlenther Onkol. 2020 May;196(5):421-443
pubmed: 32211939
Phys Med Biol. 2015 Nov 21;60(22):R323-61
pubmed: 26509844
J Magn Reson Imaging. 1993 Sep-Oct;3(5):761-9
pubmed: 8400563
AJR Am J Roentgenol. 1990 Jun;154(6):1275-83
pubmed: 2110742
Med Phys. 2017 Feb;44(2):375-381
pubmed: 28019663
Phys Med Biol. 2005 Jun 7;50(11):2651-61
pubmed: 15901960
Australas Phys Eng Sci Med. 2014 Mar;37(1):103-13
pubmed: 24519001
Pract Radiat Oncol. 2016 Nov - Dec;6(6):e319-e328
pubmed: 27523440
Magn Reson Imaging. 2016 Jun;34(5):645-53
pubmed: 26795695
Strahlenther Onkol. 2001 Feb;177(2):59-73
pubmed: 11233837
Strahlenther Onkol. 2014 Jun;190(6):521-32
pubmed: 24715242
Invest Radiol. 2013 Jan;48(1):55-60
pubmed: 23192164
AJNR Am J Neuroradiol. 2019 Jul;40(7):1140-1148
pubmed: 31221635
Med Phys. 2015 Jan;42(1):28-39
pubmed: 25563245
J Comput Assist Tomogr. 1994 Jul-Aug;18(4):509-18
pubmed: 8040430
Med Phys. 2009 Sep;36(9):3917-26
pubmed: 19810464
Clin Oncol (R Coll Radiol). 2010 Oct;22(8):688-97
pubmed: 20674300
Pract Radiat Oncol. 2018 Nov - Dec;8(6):e369-e376
pubmed: 30174247
Neuroradiology. 2002 Mar;44(3):191-203
pubmed: 11942372
Phys Med Biol. 2006 Jun 21;51(12):N253-61
pubmed: 16757858
Strahlenther Onkol. 2019 Mar;195(3):207-217
pubmed: 30386864
Phys Med Biol. 2008 Jul 7;53(13):3579-93
pubmed: 18560047
Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):199-217
pubmed: 29254773
Magn Reson Med. 2004 Jul;52(1):115-22
pubmed: 15236374
Phys Med Biol. 2009 Sep 21;54(18):5381-94
pubmed: 19687561
Radiother Oncol. 2016 Nov;121(2):187-192
pubmed: 27838146
Quant Imaging Med Surg. 2017 Apr;7(2):205-214
pubmed: 28516046
AJNR Am J Neuroradiol. 1995 Feb;16(2):373-80
pubmed: 7726087
Med Phys. 2019 Aug;46(8):3565-3581
pubmed: 31112304
Radiother Oncol. 2020 Jan;142:175-179
pubmed: 31431379

Auteurs

Florian Putz (F)

Department of Radiation Oncology, Friedrich-Alexander-University Erlangen-Nürnberg, Universitätsstraße 27, 91054, Erlangen, Germany. florian.putz@uk-erlangen.de.

Veit Mengling (V)

Department of Radiation Oncology, Friedrich-Alexander-University Erlangen-Nürnberg, Universitätsstraße 27, 91054, Erlangen, Germany.

Rosalind Perrin (R)

Department of Radiation Oncology, Friedrich-Alexander-University Erlangen-Nürnberg, Universitätsstraße 27, 91054, Erlangen, Germany.

Siti Masitho (S)

Department of Radiation Oncology, Friedrich-Alexander-University Erlangen-Nürnberg, Universitätsstraße 27, 91054, Erlangen, Germany.

Thomas Weissmann (T)

Department of Radiation Oncology, Friedrich-Alexander-University Erlangen-Nürnberg, Universitätsstraße 27, 91054, Erlangen, Germany.

Johannes Rösch (J)

Department of Radiation Oncology, Friedrich-Alexander-University Erlangen-Nürnberg, Universitätsstraße 27, 91054, Erlangen, Germany.

Tobias Bäuerle (T)

Institute of Radiology, Friedrich-Alexander-University Erlangen-Nürnberg, Ulmenweg 18, 91054, Erlangen, Germany.

Rolf Janka (R)

Institute of Radiology, Friedrich-Alexander-University Erlangen-Nürnberg, Ulmenweg 18, 91054, Erlangen, Germany.

Alexander Cavallaro (A)

Institute of Radiology, Friedrich-Alexander-University Erlangen-Nürnberg, Ulmenweg 18, 91054, Erlangen, Germany.

Michael Uder (M)

Institute of Radiology, Friedrich-Alexander-University Erlangen-Nürnberg, Ulmenweg 18, 91054, Erlangen, Germany.

Patrick Amarteifio (P)

Imaging Science Institute Erlangen, Siemens Healthineers, Ulmenweg 18, 91054, Erlangen, Germany.

Manuel Alexander Schmidt (MA)

Department of Neuroradiology, Friedrich-Alexander-University Erlangen-Nürnberg, Schwabachanlage 6, 91054, Erlangen, Germany.

Arndt Dörfler (A)

Department of Neuroradiology, Friedrich-Alexander-University Erlangen-Nürnberg, Schwabachanlage 6, 91054, Erlangen, Germany.

Sabine Semrau (S)

Department of Radiation Oncology, Friedrich-Alexander-University Erlangen-Nürnberg, Universitätsstraße 27, 91054, Erlangen, Germany.

Sebastian Lettmaier (S)

Department of Radiation Oncology, Friedrich-Alexander-University Erlangen-Nürnberg, Universitätsstraße 27, 91054, Erlangen, Germany.

Rainer Fietkau (R)

Department of Radiation Oncology, Friedrich-Alexander-University Erlangen-Nürnberg, Universitätsstraße 27, 91054, Erlangen, Germany.

Christoph Bert (C)

Department of Radiation Oncology, Friedrich-Alexander-University Erlangen-Nürnberg, Universitätsstraße 27, 91054, Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH